Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 90YIEHRFJ9

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Leukocyte surface antigen CD47 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myelodysplastic Syndromes 3 D009190 ClinicalTrials
Leukemia, Myeloid, Acute 3 D015470 ClinicalTrials
Triple Negative Breast Neoplasms 2 D064726 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Hodgkin Disease 2 D006689 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials
Sezary Syndrome 1 D012751 ClinicalTrials
Mycosis Fungoides 1 D009182 ClinicalTrials
Colorectal Neoplasms 1 D015179 ClinicalTrials
Urinary Bladder Neoplasms 1 D001749 ClinicalTrials
Urinary Bladder Neoplasms 1 D001749 ClinicalTrials
Ovarian Neoplasms 1 D010051 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 1 D016403 ClinicalTrials
Hematologic Neoplasms 1 D019337 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297985
FDA SRS 90YIEHRFJ9